Private Equity

With its strategic pivot to high-growth Med Tech paying off, all eyes are on AngioDynamics' CEO presentation at the upcoming Leerink healthcare conference.

The environmental services giant surpassed 2025 targets, driven by its GreenUp strategy, major acquisitions in water tech, and a renewed global push.

The therapy giant reports robust revenue growth and record patient visits, backed by major acquisitions and new 10-year hospital system alliances.

Asbury Automotive nets $210M from strategic dealership sales, funneling capital into debt reduction and a massively expanded share repurchase program.

As Tennessee's hospitality sector booms, one company is integrating kitchen design and equipment supply to help restaurants open faster than ever.

With broadband subscribers declining and competition mounting, all eyes are on Co-CEO Mike Cavanagh to outline Comcast's strategy at a key TMT conference.

Pennant Group posts record revenue and an aggressive 2026 outlook, but rapid expansion and regulatory headwinds present a complex path forward for the provider.

MiMedx reports record 2025 sales and a $100M buyback, but faces a major challenge from new Medicare reimbursement rules set to disrupt the wound care market.

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

The water midstream leader's inaugural dividend signals financial confidence, but a look at its balance sheet reveals a complex picture of growth and debt.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

A new documentary focusing on resilience after 9/11 is gaining global acclaim, merging powerful filmmaking with a mission to educate future generations.

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.

Eton Pharmaceuticals wins landmark FDA approval for DESMODA, a breakthrough liquid drug set to transform care for a rare condition by enabling precise, safe dosing.

Silfab Solar appoints financial veteran Phung Ngo-Burns as CFO, a strategic move to navigate its major U.S. expansion amid a booming domestic solar market.

BearCom installs its executive chairman as interim CEO, a move signaling a focused push to dominate the converging security and communications markets.

A $1.12M Baltimore deal for an Ethiopian investor reveals how private capital is bypassing traditional banks to fuel global investment in American property.

Following a record year, Fingerpaint Group elevates veteran insiders to top roles, proving its culture-first succession strategy is a blueprint for success.

A new lineup of seasonings taps into global, comfort, and sweet-heat trends to help meat processors navigate a volatile and competitive market.

As CFO Jim Kelly retires, Orbia promotes Cristian Capellino, the architect of its finance modernization, ensuring strategic continuity and focus on growth.